drugset / Trial / NCT00192374
Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children
Phase 3
Completed
1920 enrolled
MedImmune LLC
Wyeth is now a wholly owned subsidiary of Pfizer · collab
RandomizedSingle-groupDouble-blindTreatment
Summary
\- Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of(CAIV-T) in Healthy Children.
Timeline
- Start
- 2002-02
- Primary completion
- —
- Completion
- 2002-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FluMist | Vaccine | — | — |
Indications
No indication recorded.